Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel protein kinase inhibitors in early development at Aventis

Feb. 10, 2003

Millennium submits MAA for Velcade in E.U.

Feb. 7, 2003

Corixa reacquires North American rights to lung cancer vaccines

Feb. 7, 2003

Tricyclic antitumor agents covered by Yung Shin patent

Feb. 7, 2003

Vion awarded SBIR grant for further Tapet studies

Feb. 7, 2003

Novel tyrosine kinase inhibitors in Merck pipeline

Feb. 7, 2003

Novel cytotoxic metabolite isolated from marine bacterium

Feb. 6, 2003

AES-14 granted fast track status for oral mucositis associated with cancer chemotherapy

Feb. 6, 2003

Japanese marketing approval sought for Glivec for GIST indication

Feb. 6, 2003

Schering presents new VEGF inhibitors

Feb. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...